Synlett 2010(5): 721-724  
DOI: 10.1055/s-0029-1219385
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Direct Synthesis of N-Aryl Derivatives of Quinazolin-4(3H)-ones Employing Arylboronic Acids in the Presence of Cu(OAc)2

Kintali Sreeramamurthy, Ettam Ashok, Velisoju Mahendar, Gourishetti Santoshkumar, Parthasarathi Das*
Discovery Research, Dr. Reddy’s Laboratories Ltd., Bollaram Road, Miyapur, Hyderabad 500049, AP, India
Fax: +91(40)23045438; e-Mail: parthads@yahoo.com;
Further Information

Publication History

Received 7 September 2009
Publication Date:
10 February 2010 (online)

Abstract

Copper-promoted N-arylation of quinazolin-4(3H)-ones with boronic acid at room temperature in the presence of air has been investigated. This method is general and can be applied to synthesizing derivatives of quinazolin-4(3H)-one with medicinal values.

    References and Notes

  • 1a Armarego WLF. Quinazolines   Brown DJ. John Wiley and Sons; London: 1967. 
  • 1b Ellis GP. Synthesis of Fused Heterocycles   Vol. 47:  John Wiley and Sons; Chichester: 1987. 
  • 1c Hermecz I. Kokosi J. Podanyi B. Szasz G. Heterocycles  1994,  37903 
  • 1d For review on quinazolinone, see: Mhaske SB. Argade NP. Tetrahedron  2006,  62:  9787 
  • 2 Fowler KW, Huang D, Kesicki EA, Ooi HC, Oliver AR, Ruan F, and Treiberg J. inventors; WO 2005113556, 2005-6, US  16778.  ; Chem. Abstr. 2006, 144, 22759
  • 3 Jiang JB. Hesson DP. Dusak BA. Dexter DL. Kang GJ. Hamel E. J. Med. Chem.  1990,  33:  1721 
  • 4 Lowe JA. Archer RL. Chapin DS. Cheng JB. Helweg D. Johnson JL. Koe BK. Lebel LA. Moore PF. Nielsen JA. Russo LL. Shirley JT. J. Med. Chem.  1991,  34:  624 
  • 5 Rudolph J. Esler WP. O’Connor S. Coish PDG. Wickens PL. Brands M. Bierer DE. Bloomquist BT. Bondar G. Chen L. Chuang C.-Y. Claus TH. Fathi Z. Fu W. Khire UR. Kristie JA. Liu X.-G. Lowe DB. McClure AC. Michels M. Ortiz AA. Ramsden PD. Schoenleber RW. Shelekhin TE. Vakalopoulos A. Tang W. Wang L. Yi L. Gardell SJ. Livingston JN. Sweet LJ. Bullock WH. J. Med. Chem.  2007,  50:  5202 
  • 6a Katritzky AR. Rees CW. The Structure, Reaction, Synthesis and Uses of Heterocyclic Compounds, In Comprehensive Heterocyclic Chemistry   Part 2B, Vol. 3:  Pergamon Press; New York: 1984. 
  • 6b Pelletier SW. Alkaloids: Chemical and Biological Prospective   Vol. 1:  John Wiley and Sons; New York: 1983. 
  • 7 Takeuchi Y. Koike M. Azuma K. Nishioka H. Abe H. Kim H.-S. Wataya Y. Harayama T. Chem. Pharm.  2001,  49:  721 
  • 8a Tsantrizos YS. Xu X.-J. Can. J. Chem.  1993,  71:  1362 
  • 8b Wang H. Genesan A. J. Org. Chem.  1998,  63:  2432 
  • 8c He F. Snider BB. J. Org. Chem.  1999,  64:  1397 
  • 8d Sugimori T. Okawa T. Egushi S. Kakehi A. Yashima E. Okamoto Y. Tetrahedron  1998,  54:  7997 
  • 9a Kotsuki H. Sakai H. Morimoto H. Suenaga H. Synlett  1999,  1993 
  • 9b Khosropour AR. Mohammafpoor-Baltork I. Ghorbankhani H. Tetrahedron Lett.  2006,  47:  3561 
  • 9c Narasimhulu M. Mahesh KC. Reddy TS. Rajesh K. Venkateswarlu Y. Tetrahedron Lett.  2006,  47:  4381 
  • 10a Kametani T. Loc CV. Higa T. Koizumi M. Ihara M. Fukumoto K. J. Am. Chem. Soc.  1997,  99:  2306, 
  • 10b Connolly DJ. Guiry PJ. Synlett  2001,  1707 
  • 10c Wang L. Xia J. Qin F. Qin C. Sun J. Synthesis  2003,  1241 
  • 11 Salehi P. Dabiri M. Zolfigol MA. Bahgbanzadeh M. Tetrahedron Lett.  2004,  46:  7151 
  • 12 Xue S. McKenna J. Shieh WC. Repi O. J. Org. Chem.  2004,  69:  6474 
  • 13 Shi D. Rong L. Wang J. Zhuang Q. Wang X. Hu H. Tetrahedron Lett.  2003,  44:  3199 
  • 14a Kamal A. Reddy KS. Prasad BR. Babu AH. Ramana AV. Tetrahedron Lett.  2004,  45:  6-517  
  • 14b Kalusa A. Chessum N. Jones K. Tetrahedron Lett.  2008,  49:  5840 
  • 15a Chan DMT. Monaco KL. Wang R.-P. Winters MP. Tetrahedron Lett.  1998,  39:  2933 
  • 15b Lam PYS. Clark CG. Saubern S. Adams J. Winters MP. Chan DMT. Combs A. Tetrahedron Lett.  1998,  39:  2941 
  • 15c Chan DMT. Lam PYS. Recent Advances in Copper-Promoted C-Heteroatom Bond Cross-Coupling Reaction with Boronic Acids and Derivatives, In Boronic Acids: Preparation and Application in Organic Synthesis and Medicine   Hall DG. Wiley-VCH; Weinheim: 2005.  p.205 
  • 16a Lam PYS. Deudon S. Averil KM. Li R. He M. DeShong P. Clark CG. J. Am. Chem. Soc.  2000,  122:  7600 
  • 16b Lam PYS. Vincent G. Bonne D. Clark CG. Tetrahedron Lett.  2002,  43:  3091 
  • 16c Chan DMT. Monaco KL. Li R. Bonne D. Clark CG. Lam PYS. Tetrahedron Lett.  2003,  44:  3863 
  • 17a Evans DA. Katz JL. Peterson GS. Hinterman T. J. Am. Chem. Soc.  2001,  123:  12411 
  • 17b Collman JP. Zhong M. Zhang C. Costanzo S. Org. Lett.  2001,  66:  7892 
  • 17c Savarin C. Srogl J. Liebeskind LS. Org. Lett.  2002,  4:  4309 
  • 17d Bakkestuen AK. Gundersen L.-L. Tetrahedron Lett.  2003,  44:  3359 
  • 17e Strouse JJ. Jeselnik M. Tapaha F. Jonsson CB. Parker WB. Arterburn JB. Tetrahedron Lett.  2005,  46:  5699 
  • 17f Benard S. Neuville L. Zhu J. J. Org. Chem.  2008,  73:  6441 
  • 17g Guy CS. Jones TC. Synlett  2009,  2253 
  • 19 Ple PA. Green TP. Hennequin LF. Curwen J. Fennel M. Allen J. van der Brempt CL. Costello G. J. Med. Chem.  2004,  47:  871 
18

General Procedure for N-Arylation of 4 (3 H )-Quinazolinone
A mixture of the requisite 4 (3H)-quinazolinone (1.0 mmol), phenylboronic acid (1.5 mmol), anhyd Cu(OAc)2 (1.0 mmol) and Et3N (2.0 mmol) in dry CH2Cl2 (10-15 mL) was stirred at ambient temperature under air for 24-70 h. Progress of the reaction was monitored by TLC. The reaction mixture was filtered through Celite, the filtrate concentrated in vacuo, and the resulting mixture purified by chromatography on silica gel (CH2Cl2-MeOH) to yield the corresponding N-substituted quinazolin-4 (3H)-one.
Selected Spectroscopic DataTable 1, Entry 6
Brown solid; mp 221-223 ˚C. IR (KBr): 3105, 3043, 2976, 2495, 1928 1614 cm-1. ¹H NMR (400 MHz, DMSO-d 6): δ = 8.37 (s, 1 H), 8.14-8.12 (m, 1 H,), 7.95-7.93 (m, 1 H), 7.80-7.78 (m, 1 H), 7.62-7.60 (m, 2 H), 7.42-7.45 (m, 2 H). ¹³C NMR (50 MHz, CDCl3): δ = 159.0, 147.6, 146.4, 134.6, 131.6, 129.8, 129.6, 125.2, 116.2, 115.7. ESI-MS: 275 [M + H]+. ESI-HRMS: m/z calcd for C14H9ClFN2O [M + H]+: 275.0387; found: 275.0383.
Table 1, Entry 7
Brown solid; mp 194-196 ˚C. IR (KBr): 3066, 2981, 2939, 2727, 1681, 1556 cm. ¹H NMR (400 MHz, DMSO-d 6): δ = 8.32 (s, 1 H), 8.17-8.15 (m, 1 H), 7.97-7.95 (m, 1 H) 7.76-7.73 (m, 1 H), 7.12-7.10 (m, 1 H), 7.03-6.98 (m, 2 H), 4.30 (s, 4 H). ¹³C NMR (50 MHz, CDCl3): δ = 159.0, 147.7, 146.3, 143.7, 143.2, 134.5, 131.4, 130.2, 129.4, 125.2, 123.1, 120.1, 117.0, 116.3, 64.0. ESI-MS: 315 [M + H]+. ESI-HRMS): m/z calcd for C16H12ClN2O3 [M + H]+: 315.0536; found: 315.0529.
Table 1, Entry 8
Brown solid; mp 190-192 ˚C. IR (KBr): 3086, 3026, 2962, 2654, 1739, 1610 cm. ¹H NMR (400 MHz, DMSO-d 6): δ = 8.24 (s, 1 H), 7.58-7.48 (m, 6 H,), 7.20-7.18 (m, 1 H), 3.94 (s, 3 H), 3.89 (s, 3 H). ¹³C NMR (50 MHz, CDCl3): δ = 159.2, 154.6, 148.9, 145.6, 143.8, 137.7, 129.1, 128.5, 127.4, 114.8, 108.0, 105.4, 56.0, 55.7. ESI-MS: m/z = 283 [M + H]+. ESI-HRMS: m/z calcd for C16H15N2O3 [M + H]+: 283.1083; found: 283.1081.
Table 1, Entry 9
Brown solid; mp 243-245 ˚C. IR (KBr): 3433, 3060, 2962, 2837, 1683, 1610, 1502 cm. ¹H NMR (400 MHz, DMSO-d 6): δ = 8.22 (s, 1 H), 7.49-7.47 (m, 1 H), 7.46-7.44 (m, 1 H), 7.39-7.37 (m, 2 H), 7.19-7.17 (m, 1 H), 3.94 (s, 3 H), 3.88 (s, 3 H), 2.30 (s, 3 H). ¹³C NMR (50 MHz, CDCl3): δ = 161.4, 159.2, 154.68, 148.99, 145.64, 143.84, 133.65, 130.68, 126.9, 125.3, 115.6, 114.7, 108.0, 105.3, 56.02, 55.75, 14.07. ESI-MS: m/z 315 [M + H]+. ESI-HRMS: m/z calcd for C17H16FN2O3 [M + H]+: 315.1145; found: 315.1143.

20

Selected Spectroscopic DataTable 2, Entry 2
Brown solid; mp 125-127 ˚C. IR (KBr): 3429, 3076, 2954, 2495, 2854 2445, 1678 cm. ¹H NMR (400 MHz, DMSO-d 6): δ = 8.22 (s, 1 H), 7.60-7.58 (m, 2 H,), 7.56-7.54 (m, 1 H), 7.40-7.36 (m, 2 H), 7.20-7.18 (m, 1 H), 4.20-4.18 (m, 2 H), 3.85 (s, 3 H), 3.60-3.58 (m, 4 H), 2.46-2.38 (m, 6 H), 1.96-1.94 (m, 2 H). ¹³C NMR (50 MHz, CDCl3): δ = 164.0, 159.0, 153.9, 149.0, 145.5, 143.7,134.0, 133.8, 129.7, 129.5, 116.0, 115.6, 114.6, 108.6, 105.5, 66.9, 64.8, 55.7, 54.6, 53.0, 25.4. ESI-MS: 414 [M + H]+. ESI-HRMS: m/z calcd for C22H25FN3O4 [M + H]+: 414.1829; found: 414.1830.